Acumen Pharmaceuticals Inc Return on Net Assets (RONA) 2 year CAGR is -53.05% for the Trailing 12 Months (TTM) ending March 31, 2024, a 20.02% change year over year. Return on net assets measures the profitability of a company relative to its net assets, which include total non-current assets and working capital. It is calculated by dividing the net income by the sum of total non-current assets and working capital. This ratio indicates the return generated for each unit of net asset investment made by the company. A higher return on net assets suggests better profitability and efficient utilization of the company's asset base. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.